Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

Moderna said it plans to cut $1.1 billion in expenses by 2027 as it charts a path forward after the rapid decline of its Covid business. The biotech company said it expects 10 new product ...

Opinions expressed by Forbes Contributors are their own. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. While the application of data and AI holds the potential to ...

12:20 PM ESTHealth Care Former Moderna executive to lead Blumberg Institute in Bucks County Former Moderna executive to lead Blumberg Institute in Bucks County ...

Moderna President Stephen Hoge, M.D., has taken on an expanded role, adding new responsibilities overseeing Moderna’s commercial organization. As President, Dr. Hoge will now be responsible for ...

18 analysts have expressed a variety of opinions on Moderna MRNA over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of ...

Get a deeper insight into the potential performance of Moderna (MRNA) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates ...